________________________________________________________________________________________________________________________________

(C) B2Bioworld 2011Upcoming Opportunities in the German M&A Market

May 2011. German small business banks (Mittelstandsbanken) are preparing for the next wave of trade sales in the country. Recently BayBG which is one of the two largest small business financiers together with MBG Baden-Wuerttemberg explained the strategy aligning with innovation policies of the Laender.

 

If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)

Article free of advertisement - 4 pages
- Includes data on sector investments and Land engagements by small business banking of Germany sector 2008/2009/2010;
- Structure of small business bank typical workings

Full Company License enquire here

Back to section

Related Editorial Articles

Is that worth a dollar, or a million dollars?
Ed Torres, Managing Director of Lilly Ventures on the Fund’s input to Eli Lilly’s business development

Metrics for Disease, Health, and Wellness
Personalized medicine? A systems look at human genetic diagnostics and the road ahead for next-generation sequencing by Leroy Hood, Institute for Systems Biology at Seattle

Patenting Stem Cells – Behind the front stages

Sustainability refers to more than “green” or “bio-based”
Giorgio Squinzi, President of construction chemicals corporation MAPEI SpA and of Italy’s Confindustria

Bio-based economy? What's in it for business
An industry perspective and key trends in an emerging lead market

Horizon Discovery: Mitigating risks and developing the U.S. business

Roche Ethiopia: Build-up of an emerging market

Resolving the Innovation Paradox
Günter von Au, Vice-Chairman of Board, Clariant AG and former CEO of Süd-Chemie. Includes an assessments of CHOREN’s failure and the Brazilian demand for cellulosic ethanol

Sandro Aruffo’s Syngenta Legacy
The late Head of R&D and Robert Berendes, Head of Business Development in a candid conversation about plant biotechnology, cross-fertilization with organic farming, agrichemicals, and prospects in Africa and Asia

Cellulosic Ethanol Plant to Go or Not to Go
Steve Hartig, General Manager for Licensing with POET-DSM and also responsible for business development of Dutch DSM Bio-Based Products and Services details the business case coping with diverse political support and sticking hard on competitors

Riding ahead demand in the trade fair industry
Jochen Köckler of Deutsche Messe AG about strategic assumptions and business in different parts of the world